Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3091930
Max Phase: Preclinical
Molecular Formula: C36H47ClN6O4S3
Molecular Weight: 724.01
Molecule Type: Small molecule
Associated Items:
ID: ALA3091930
Max Phase: Preclinical
Molecular Formula: C36H47ClN6O4S3
Molecular Weight: 724.01
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCn1c(=O)/c(=C2\Sc3cc(OC)ccc3N2C)s/c1=C\c1cccc[n+]1CCCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21.[Cl-]
Standard InChI: InChI=1S/C36H46N6O4S3.ClH/c1-4-42-31(49-33(34(42)44)35-40(2)27-17-16-25(46-3)22-29(27)48-35)21-24-13-9-12-20-41(24)19-11-6-5-10-18-37-30(43)15-8-7-14-28-32-26(23-47-28)38-36(45)39-32;/h9,12-13,16-17,20-22,26,28,32H,4-8,10-11,14-15,18-19,23H2,1-3H3,(H2-,37,38,39,43,45);1H/b35-33+;/t26-,28-,32-;/m0./s1
Standard InChI Key: JPSWRULQKIRWQG-XZSOOZFNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 724.01 | Molecular Weight (Monoisotopic): 723.2815 | AlogP: 3.76 | #Rotatable Bonds: 15 |
Polar Surface Area: 108.58 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.49 | CX Basic pKa: | CX LogP: 0.79 | CX LogD: 0.79 |
Aromatic Rings: 3 | Heavy Atoms: 49 | QED Weighted: 0.12 | Np Likeness Score: -0.73 |
1. Li X, Srinivasan SR, Connarn J, Ahmad A, Young ZT, Kabza AM, Zuiderweg ER, Sun D, Gestwicki JE.. (2013) Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents., 4 (11): [PMID:24312699] [10.1021/ml400204n] |
Source(1):